Consolidated Balance Sheet (IFRS)

  Note   30 September 2014
(unaudited) 
31 Dec. 2013
(audited) 
ASSETS
Current Assets
Cash and Cash Equivalents   74,009,464 71,873,696
Available-for-sale Financial Assets   93,404,163 188,360,354
Bonds, Available-for-sale   4,979,250 11,102,087
Accounts Receivable   13,441,979 10,270,322
Income Tax Receivables   690,760 77,743
Other Receivables 3 191,985,326 119,458,330
Inventories, Net   544,702 731,009
Prepaid Expenses and Other Current Assets   2,493,700 4,693,943
Total Current Assets 381,549,344 406,567,484
Non-current Assets
Property, Plant and Equipment, Net   3,390,368 2,168,189
Patents, Net   7,246,598 7,834,711
Licenses, Net   547,674 5,396,516
Intangible Assets under Development   28,254,201 12,807,800
Software, Net   1,887,999 1,758,026
Goodwill   7,352,467 7,352,467
Shares, Available-for-Sale, Net of Current Portion   1,726,633 1,726,633
Deferred Tax Asset   977,028 313,372
Prepaid Expenses and Other Assets, Net of Current Portion 1,143,298 1,731,548
Total Non-current Assets   52,526,266 41,089,262
Total Assets 434,075,610 447,656,746

See accompanying Notes

  Note   30 June 2014
(unaudited) 
31 Dec. 2013
(audited) 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts Payable and Accrued Expenses   18,441,198 17,190,021
Tax Liabilities   450,293 2,690,282
Provisions   45,256 260,000
Current Portion of Deferred Revenue   17,604,060 15,266,877
Total Current Liabilities 36,540,807 35,407,180
Non-current Liabilities
Provisions, Net of Current Portion   966,199 636,941
Deferred Revenue, Net of Current Portion   48,189,926 59,168,599
Convertible Bonds due to Related Parties   273,047 298,606
Deferred Tax Liabilities   262,231 0
Total Non-current Liabilities 49,691,403 60,104,146
Total Liabilities   86,232,210 95,511,326
     
Stockholders' Equity
Common Stock 5 26,392,084 26,220,882
Ordinary Shares Issued (26,372,584 and 26,220,882
for 2014 and 2013, respectively)
     
Ordinary Shares Outstanding (25,921,694 and 25,880,992
for 2014 and 2013, respectively)
Treasury Stock (450,890 and 339,890 shares
for 2014 and 2013, respectively), at Cost
5 (14,251,962) (6,418,018)
Additional Paid-in Capital 5 316,512,505 310,963,651
Revaluation Reserve 5 (40,923) 240,381
Translation Reserve 5 293,793 192,556
Accumulated Income   18,937,903 20,945,968
Total Stockholders' Equity 347,843,400 352,145,420
Total Liabilities and Stockholders' Equity 434,075,610 447,656,746

See accompanying Notes

Top